Compare QNCX & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | PEW |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 84.9M |
| IPO Year | 2019 | N/A |
| Metric | QNCX | PEW |
|---|---|---|
| Price | $0.11 | $2.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $10.00 | $6.75 |
| AVG Volume (30 Days) | ★ 67.7M | 288.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $2.55 |
| 52 Week High | $4.55 | $10.04 |
| Indicator | QNCX | PEW |
|---|---|---|
| Relative Strength Index (RSI) | 27.94 | 51.34 |
| Support Level | $0.09 | $2.74 |
| Resistance Level | $0.98 | $3.64 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 21.43 | 53.68 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition, and related accessories.